IMMUNOPRECISE ANTIBODIES LTD's ticker is and the CUSIP is 45257F900. A total of 3 filers reported holding IMMUNOPRECISE ANTIBODIES LTD in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $45,567 | -57.8% | 24,900 | -31.8% | 0.00% | – |
Q2 2023 | $108,040 | -24.8% | 36,500 | -29.7% | 0.00% | -100.0% |
Q1 2023 | $143,763 | -83.2% | 51,900 | -67.9% | 0.00% | -50.0% |
Q4 2022 | $856,480 | +54.6% | 161,600 | +16.4% | 0.00% | +100.0% |
Q3 2022 | $554,000 | +11.5% | 138,800 | +7.8% | 0.00% | 0.0% |
Q2 2022 | $497,000 | -4.4% | 128,800 | +27.3% | 0.00% | 0.0% |
Q1 2022 | $520,000 | +52.5% | 101,200 | +58.9% | 0.00% | – |
Q4 2021 | $341,000 | +278.9% | 63,700 | +339.3% | 0.00% | – |
Q3 2021 | $90,000 | – | 14,500 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
GROUP ONE TRADING, L.P. | 24,900 | $45,567 | 0.00% |
SIMPLEX TRADING, LLC | 400 | $0 | 0.00% |